Key Highlights

  • AEHR shares fell 8.06% to $104.20 in pre-market trading after closing the previous session at $113.33.
  • Rising Treasury yields and more hawkish Federal Reserve expectations pressured technology and semiconductor stocks.
  • Profit-taking followed an approximately 18% rally driven by a new silicon-photonics testing order.

Technology Selloff Pressures AEHR Stock

Aehr Test Systems (NASDAQ: AEHR) shares declined 8.06% to $104.20 in pre-market trading on June 23, 2026, as of the latest available update.

The stock had closed the previous session at $113.33, down 1.71%, after briefly benefiting from strong buying linked to a new semiconductor-testing order.

The immediate pre-market weakness appears to reflect two connected factors. Investors were taking profits after an outsized rally, while broader technology shares were falling amid rising Treasury yields and expectations that the Federal Reserve could maintain tighter monetary policy for longer.

The Technology Select Sector SPDR Fund was down roughly 3% in early trading, while the Nasdaq had declined about 1.3% during Monday’s session. This wider market pressure increased selling across high-growth and richly valued semiconductor stocks.

Aehr develops semiconductor test and burn-in systems used for AI processors, silicon-photonics devices, power semiconductors and other high-performance computing components.

Higher Treasury Yields Raise Valuation Pressure

Growth stocks are particularly sensitive to changes in Treasury yields because much of their valuation depends on profits expected several years into the future.

When yields rise, the present value of those future earnings declines. Investors may therefore demand lower valuation multiples for companies whose current revenue and earnings remain modest relative to their market capitalisation.

This dynamic is relevant for Aehr. At the previous closing price, the company had a market value of approximately $3.56 billion despite reporting losses and relatively limited recent revenue.

The market has assigned a substantial premium to Aehr because of its exposure to AI processors, advanced semiconductor packaging and optical data-centre infrastructure. That premium can expand quickly when orders are announced, but it can also contract sharply when interest-rate expectations become less supportive.

Profit-Taking Follows Silicon-Photonics Rally

The macro selloff followed a strong company-specific rally.

Aehr recently announced a follow-on order from a major networking company for a complete FOX wafer-level burn-in production cell. The equipment will be used to test silicon-photonics transceivers serving hyperscale data-centre applications.

The order strengthened expectations that Aehr could benefit from rising demand for optical interconnects. These technologies are increasingly important as AI data centres require faster and more energy-efficient connections between processors, memory and networking equipment.

The customer had already received initial engineering and production systems, suggesting that Aehr’s technology was moving from evaluation into manufacturing deployment.

The announcement helped lift AEHR shares by approximately 18% during an earlier session. The scale of that move left the stock vulnerable to profit-taking, particularly when the wider technology sector weakened.

AI Orders Support the Long-Term Growth Case

Aehr’s growth narrative extends beyond silicon photonics.

The company previously disclosed a $41 million production order from a lead hyperscale customer for package-level burn-in systems used to test high-power AI processors. Management has indicated that strong bookings could support a meaningful revenue acceleration in fiscal 2027.

Semiconductor burn-in testing is becoming more important as processors increase in cost, power consumption and technical complexity. Manufacturers need to identify defective components before they are integrated into expensive computing systems.

This creates a structural opportunity for Aehr. However, bookings must still convert into equipment deliveries, recognised revenue and improving margins before the financial value becomes fully visible.

Financial Performance Still Trails Market Expectations

Aehr reported approximately $31.2 million in revenue during the first nine months of fiscal 2026, below the comparable prior-year period. The company also recorded a GAAP net loss of about $8.5 million.

These results underline the gap between Aehr’s current financial performance and the growth expectations reflected in its share price.

The company’s expanding order book may narrow that gap, but quarterly results can remain volatile because large equipment contracts depend on customer schedules, manufacturing capacity and acceptance milestones.

Risk Framework

The principal opportunity is Aehr’s exposure to AI accelerators, silicon photonics and advanced semiconductor reliability testing.

The main risks include customer concentration, delayed order conversion, continued operating losses, volatile equipment demand and valuation compression when Treasury yields rise.

The stock’s movement from a 52-week low near $11.50 to above $100 also indicates that investor positioning may be crowded, increasing the likelihood of sharp corrections.

Conclusion

The 8.06% pre-market decline in AEHR stock reflects more than simple profit-taking.

Rising Treasury yields, hawkish Federal Reserve expectations and wider technology-sector weakness created a difficult backdrop for highly valued semiconductor shares. That pressure was amplified by investors locking in gains after AEHR’s recent 18% rally.

The company’s AI and silicon-photonics order momentum remains intact, but future valuation support will depend on converting bookings into sustained revenue, stronger margins and positive cash flow.